S. SRIKANTA, M.D.; O. P. GANDA, M.D.; R. A. JACKSON, M.D.; R. E. GLEASON, Ph.D.; A. KALDANY, M.D.; M. R. GAROVOY, M.D.; E. L. MILFORD, M.D.; C. B. CARPENTER, M.D.; J. S. SOELDNER, M.D.; G. S. EISENBARTH, M.D., Ph.D.
In a prospective 21-year study, islet cell antibodies and beta cell function were serially assessed in 24 monozygotic twins initially discordant for type I diabetes mellitus. Eighteen of 21 twins typed had HLA-DR3 or HLA-DR4 antigens. During the follow-up, 4 twins developed type I diabetes mellitus, and in 3 of these 4 twins islet cell antibodies preceded the diagnosis of clinical diabetes mellitus by greater than 8, 5 and 7 years respectively. During the "prediabetic phase," the presence of islet cell antibodies was temporally associated with a progressive decline in first phase insulin response to intravenous glucose. Elevations in fasting blood glucose and abnormalities on oral glucose tolerance tests appeared only later during the course of the disease. Of the remaining 20 twins who continue to be discordant for type I diabetes mellitus, two have had islet cell antibodies for greater than 1.5 and 1 year respectively. One of these islet cell antibody-positive non-diabetic twins was restudied; despite a fasting blood glucose level of 64 mg/dL, she had a total absence of first phase insulin response to intravenous glucose. There was no evidence of transient islet cell antibody positivity in any of the twins studied. Type I diabetes mellitus in monozygotic twins has a prolonged prediabetic phase of progessive beta cell dysfunction with associated immunologic abnormalities.
SRIKANTA S, GANDA OP, JACKSON RA, et al. Type I Diabetes Mellitus in Monozygotic Twins: Chronic Progressive Beta Cell Dysfunction. Ann Intern Med. 1983;99:320–326. doi: 10.7326/0003-4819-99-3-320
Download citation file:
Published: Ann Intern Med. 1983;99(3):320-326.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism, Gastroenterology/Hepatology.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use